person

Maurizio O.

Country
Italy
Department
Neurofisiopatologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 11 partner sites.

Specializations

Inflammatory Bowel Disease

The investigator concentrates on therapeutic strategies for Crohn’s disease and ulcerative colitis, emphasizing disease activity reduction and mucosal healing.

  • Biologic therapies targeting gut inflammation
  • Small‑molecule agents for induction and maintenance
  • Biomarker‑guided treatment optimization

Research integrates pediatric and adult populations to address unmet needs in chronic intestinal disorders.

Ocular Therapeutics

Focus is placed on retinal and uveal conditions such as age‑related macular degeneration and diabetic macular edema, aiming to preserve visual acuity.

  • Intravitreal agents for neovascular disease
  • Long‑acting delivery systems for macular edema
  • Therapies addressing geographic atrophy progression

Efforts include both early‑stage and advanced disease interventions.

Infectious Diseases and HIV

Work spans viral infections, notably HIV‑1, COVID‑19, and chronic hepatitis B, with a view toward improving antiviral efficacy and safety.

  • Novel antiretroviral combination regimens
  • Therapeutics for severe respiratory viral infections
  • Vaccination and prophylaxis strategies

Studies address both treatment‑naïve and treatment‑experienced cohorts.

Neurological and Neurodevelopmental Disorders

The investigator engages in research on seizure disorders, including Dravet syndrome and Lennox‑Gastaut syndrome, as well as neurodegenerative conditions.

  • Targeted therapies for refractory epilepsy
  • Gene‑based approaches for rare neurogenetic diseases
  • Neuroprotective strategies in progressive disorders

Clinical work bridges pediatric and adult neurology.

Cardiovascular and Metabolic Health

Key interests include heart failure phenotypes and metabolic disorders such as type 2 diabetes mellitus, focusing on disease‑modifying outcomes.

  • Agents reducing cardiovascular event risk
  • Metabolic regulators improving glycemic control
  • Integrated management of obesity and renal dysfunction

Research aligns with precision medicine initiatives for high‑risk patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.